US3724462037 - GNPX - A3E3Z3 (XNCM)

GENPREX INC. DL-,0001 Acción

0,88 EUR

3,81 % 0,03 EUR 20.12.2024 21:59 - EUR - Frankfurt (XNAS) - Precios actuales y gráficos en MoneyPeak

Cotizaciones actuales de GENPREX INC. DL-,0001

Bolsa	Ticker	Moneda	Última operación	Precio	Variación diaria	Variación diaria %
NASDAQ	GNPX	USD	20.12.2024 21:59	0,92 USD	0,89 USD	3,77 %

Performance

Day	Week	Month	3 Months	6 Months	1 Year	5 Years
0,70 %	-9,90 %	-15,44 %	157,19 %	-53,20 %	-88,51 %	-89,89 %

Company Profile for GENPREX INC. DL-,0001 Share

Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas.

Company Data for GENPREX INC. DL-,0001 Share

Name GENPREX INC. DL-,0001

Company Genprex, Inc.

Symbol GNPX

Website https://www.genprex.com

Primary Exchange

Frankfurt

WKN A3E3Z3

ISIN US3724462037

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Mr. Ryan M. Confer M.S.

Country United States of America

Currency EUR

Employees 0,0 T

Address 3300 Bee Cave Road, 78746 Austin

IPO Date 2018-03-29

Ticker Symbols

Name	Symbol
Frankfurt	2DE0.F
NASDAQ	GNPX

More Shares

Investors who GENPREX INC. DL-,0001 hold also have the following shares in their portfolio:

AltC Acquisition Corp. Share

Listed Funds Trust Horizon Kinetics Energy and Remediation ETF ETF

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Jobs Community Feedback Changelog